Trial intelligence / Profile preview

Nebulized Ketamine, Magnesium Sulfate, and Lidocaine for Postoperative Sore Throat

NCT03729973Phase 3Completed

Sponsor
Zagazig University
Start
Nov 2018
Primary completion
Jan 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of ketamine, magnesium sulfate, lidocaine in postoperative sore throat (POST), sponsored by Zagazig University. Started Nov 2018; status: completed.

02

Drugs

ketaminemagnesium sulfatelidocaine
03

Conditions

postoperative sore throat (POST)

Beyond the preview

Go deeper on NCT03729973.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03729973.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call